John D Dobak's most recent trade in DermTech Inc was a trade of 56,407 Common Stock done . Disclosure was reported to the exchange on March 9, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 56,407 | 700,252 (5%) | 0% | 0 | Common Stock | |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.26 per share. | 09 Mar 2023 | 1,559 | 698,693 (5%) | 0% | 3.3 | 5,082 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.06 per share. | 07 Mar 2023 | 23,246 | 643,845 (5%) | 0% | 4.1 | 94,379 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.06 per share. | 07 Mar 2023 | 709 | 667,091 (5%) | 0% | 4.1 | 2,879 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | 27 May 2022 | 9,219 | 0 | - | - | Warrant to Purchase Common Stock | ||
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | 27 May 2022 | 9,219 | 665,295 (5%) | 0% | 1.1 | 9,957 | Common Stock | |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 11 Mar 2022 | 1,326 | 446,549 (3%) | 0% | 14.5 | 19,293 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.03 per share. | 07 Mar 2022 | 2,561 | 448,661 (3%) | 0% | 13.0 | 33,370 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.64 per share. | 07 Mar 2022 | 786 | 447,875 (3%) | 0% | 12.6 | 9,935 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.71 per share. | 13 Dec 2021 | 1,964 | 450,562 (3%) | 0% | 16.7 | 32,818 | Common Stock |
| DermTech Inc | John D Dobak | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.19 per share. | 13 Sep 2021 | 1,899 | 453,645 (3%) | 0% | 36.2 | 68,725 | Common Stock |